Barca Atlètic and Luis Enrique support rare diseases

Source:

The last weekend for a meeting between Orihuela CF and FC Barcelona youth team, Barca Atlètic, members of the Association D'Genes, next to the CEO of ERDF in Murcia, Juan Carrion Tudela, visited the hotel concentration where they were.

The players wanted to express their support and join the first team football and basketball Regal Barcelona already have done it before, showing strong solidarity and commitment to those affected.

Furthermore, the current coach, the legendary football player Luis Enrique, wanted a few words of affection and support the fight against rare diseases.

Luis Enrique thus showing their solidarity and social commitment and joined the players and personalities from different fields who have demonstrated their support for this cause, helping to raise awareness and give greater visibility to rare diseases.

From D'Genes and ERDF would like to thank FC Barcelona in their social support they are showing to the community of persons affected with rare diseases and highlight its involvement as they are doing with other disadvantaged groups and associations such as UNICEF.

noticia
Barca Atlètic and Luis Enrique support rare diseases, Foto 1
Barca Atlètic and Luis Enrique support rare diseases, Foto 2

Comment this news on Facebook

If you want to comment on this news to the administrators of Totana.net, fill out the form below:

Send notification Code: 2024418
The owner of the personal data, collected in this form, expressly authorizes Alamo Networks, S.L. to treat said data in a computerized way and to be able to incorporate it into your database. The user may exercise the rights of access, rectification, cancellation and opposition of their personal data, in the terms established by the LOPD, at the address set in C / Alamo 8, 30850, Totana (Murcia). For your convenience you can also exercise your rights by email at the address info@totana.net
This website uses cookies to facilitate and improve navigation. If you continue browsing, we consider that you accept its use. More information